Cite
MLA Citation
Sophia Stock et al.. “Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.” International journal of cancer, vol. 145, no. 5, 2019, pp. 1312–1324. http://access.bl.uk/ark:/81055/vdc_100086847263.0x00005d